Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 412 followers
Latest posts
Last updated about 8 hours ago
EyePoint shares plummet after phase 3 stumble for AMD drug-device combo Duravyu
about 8 hours ago
The phase 3 misstep could undercut EyePoint’s ambition to displace Eylea as...
Quanovate takes back marketing claims for Mira fertility wand after P&G challenge
about 9 hours ago
Quanovate voluntarily agreed to discontinue the marketing claims on its Mira fertility...
Sanofi to lay off 229 Blueprint Medicines staffers, close Cambridge offices following acquisition
about 9 hours ago
In the first major workforce reduction disclosed under new CEO Belén Garijo...
Sandoz strikes $322M biosimilars deal with Shanghai Henlius
about 11 hours ago
Sandoz has collaborated with Shanghai Henlius to gain commercialization rights to three...
Argenx heads to FDA with Vyvgart after ph. 3 win in potential blockbuster autoimmune indication
about 13 hours ago
With its latest trial readout for under-the-skin efgartigimod, argenx is adding another...
AstraZeneca touts Enhertu, Orpathys dual lung cancer wins amid bispecific failure
about 13 hours ago
AstraZeneca reported phase 3 lung cancer wins for Enhertu and a combination...
Danish politicians call out Eli Lilly obesity campaign
about 14 hours ago
Politicians and health group leaders in Denmark are calling out Eli Lilly’s...
Inside agency view: Real Chemistry’s Frank Mazzola on audience nuance and rewarding creativity
about 15 hours ago
The pharmaceutical industry creates some of the most valuable products in human...
It's BMS vs. Celgene investors once more after U.S. appeals court revives lawsuit
4 days ago
A U.S. appeals court has revived a lawsuit filed by Celgene shareholders...
How consumerization is reshaping pharma marketing
4 days ago
GLP-1s, AI and telemedicine are changing patient behavior. Learn what it means...
Tavneos trial flagged for 'serious breaches' of protocol as EU regulators dissect market withdrawal decision
4 days ago
With the European Union formally reversing its marketing authorization for rare disease...
BMS bags first FDA approval for CELMoD franchise with Zenbexus multiple myeloma nod
4 days ago
In a historic breakthrough for targeted protein degradation, BMS has secured the...